In silico screening strategies for novel inhibitors of parasitic diseases

By Ferreira Rafaela S   Guido Rafael VC   Andricopulo Adriano D   Oliva Glaucius  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 481-489

Informa Healthcare

Access to resources Recommend Favorite

In silico fragment-based drug design

By Konteatis Zenon D  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1047-1065

Informa Healthcare

Access to resources Recommend Favorite

New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni   Veljkovic Nevena   Crespan Emmanuele   Spadari Silvio   Prljic Jelena   Perovic Vladimir   Glisic Sanja   Veljkovic Veljko  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

In silico analysis of antifungal peptides

By Soltani Saeed   Keymanesh Keykhosrow   Sardari Soroush  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 837-847

Informa Healthcare

Access to resources Recommend Favorite

Development of drugs for Epstein–Barr virus using high-throughput in silico virtual screening

By Li Ning   Thompson Scott   Jiang Hualiang   Lieberman Paul M   Luo Cheng  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 12, 2010-12 ,pp. : 1189-1203

Informa Healthcare

Access to resources Recommend Favorite